Vincerx Pharma, Inc. Restricted Cash, Current
Vincerx Pharma, Inc. had Restricted Cash, Current of $82.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2025-05-15
- 2025-03-31: Restricted Cash, Current $82.00K.
- 2024-12-31: Restricted Cash, Current $79.00K.
- 2024-09-30: Restricted Cash, Current $85.00K.
- 2024-06-30: Restricted Cash, Current $82.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2025-03-31 | $82.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $79.00K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $85.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $82.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $82.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $72.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $70.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $70.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $70.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $70.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $64.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $63.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $67.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $105.00K 10-K · filed 2023-03-28 |